The effect of INC1 and INC2 test compounds in the transplant model of psoriasis.

The effect of INC1 and INC2 test compounds in the transplant model of psoriasis. - Transplant model of psoriasis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON45789

Enrollment

Registered

2018-12-17

Start date

2019-02-25

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with moderate to severe psoriasis

Exclusion criteria

Exclusion criteria: Volunteers undergoing UV/light therapy or taking systemic drugs such as cyclosporin A or methotrexate Volunteers using local topical corticosteroids Volunteers developing Köbner phenomenon at wound sites

Design outcomes

Primary

Measure	Time frame
Effect on typical psoriasis skin features after treatment with INC1 and INC2 test compounds.	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results